Gandouling Tablets Inhibit Excessive Mitophagy in Toxic Milk (TX) Model Mouse of Wilson Disease via Pink1/Parkin Pathway
Objective. Gandouling (GDL) tablet is a Chinese patent medicine approved by the National Medical Product Administration, which is used to treat Wilson disease (WD) in China. In this study, we aimed to investigate the effects of GDL on mitophagy in the hippocampus in the toxic milk (TX) mouse model o...
Main Authors: | Jing Zhang, Lu-Lu Tang, Liang-Yong Li, Shen-Wei Cui, Shan Jin, Huai-Zhen Chen, Wen-Ming Yang, Dao-Jun Xie, Gu-Ran Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/3183714 |
Similar Items
-
Clinical effect of intervention with Gandouling tablets in the perioperative period of splenectomy in patients with Wilson’s disease accompanied by splenomegaly and hypersplenism
by: MA Shouliang
Published: (2019-03-01) -
Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila
by: Tom Cornelissen, et al.
Published: (2018-05-01) -
PINK1/Parkin-Mediated Mitophagy Promotes Resistance to Sonodynamic Therapy
by: Lin Song, et al.
Published: (2018-09-01) -
Involvement of PINK1/parkin-mediated mitophagy in ZnO nanoparticle-induced toxicity in BV-2 cells
by: Wei L, et al.
Published: (2017-03-01) -
Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy
by: Ruru Li, et al.
Published: (2019-01-01)